Focus on Asthma Care

Back to articles

Leukotriene antagonists for first-line or add-on asthma therapy

KEY POINT

In patients with asthma, leukotriene-receptor antagonists (LTRAs) managed the disease just as successfully as inhaled glucocorticoid for first-line therapy or long-acting beta-2 agonist as add-on therapy.

SOURCES

Price D et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med. 2011;364:1695–707.

Dahlén S et al. Asthma treatment guidelines meet the real world [editorial]. N Engl J Med. 2011;364:1769–70.